541 related articles for article (PubMed ID: 33275998)
1. Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.
Abdelgawad IY; Sadak KT; Lone DW; Dabour MS; Niedernhofer LJ; Zordoky BN
Pharmacol Ther; 2021 May; 221():107751. PubMed ID: 33275998
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors.
Abdelgawad IY; Agostinucci K; Zordoky BN
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166352. PubMed ID: 35041996
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
4. Ionizing Radiation-Induced Endothelial Cell Senescence and Cardiovascular Diseases.
Wang Y; Boerma M; Zhou D
Radiat Res; 2016 Aug; 186(2):153-61. PubMed ID: 27387862
[TBL] [Abstract][Full Text] [Related]
5. Anthracycline chemotherapy, vascular dysfunction and cognitive impairment: burgeoning topics and future directions.
Maurer GS; Clayton ZS
Future Cardiol; 2023 Sep; 19(11):547-566. PubMed ID: 36354315
[TBL] [Abstract][Full Text] [Related]
6. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
7. Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity.
Kang DW; Wilson RL; Christopher CN; Normann AJ; Barnes O; Lesansee JD; Choi G; Dieli-Conwright CM
Front Cardiovasc Med; 2021; 8():805735. PubMed ID: 35097024
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection in cancer therapy: novel insights with anthracyclines.
Raber I; Asnani A
Cardiovasc Res; 2019 Apr; 115(5):915-921. PubMed ID: 30726931
[TBL] [Abstract][Full Text] [Related]
9. Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology.
Abdelgawad IY; Grant MKO; Zordoky BN
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875799
[TBL] [Abstract][Full Text] [Related]
10. The Achilles' heel of cancer survivors: fundamentals of accelerated cellular senescence.
Shafqat S; Arana Chicas E; Shafqat A; Hashmi SK
J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35775492
[TBL] [Abstract][Full Text] [Related]
11. Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions.
Chen JJ; Wu PT; Middlekauff HR; Nguyen KL
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H213-H222. PubMed ID: 27923793
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity: anthracyclines and long term cancer survivors.
Patanè S
Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
[No Abstract] [Full Text] [Related]
13. Chronic cardiovascular toxicity in the older oncology patient population.
Findlay SG; Gill JH; Plummer R; DeSantis C; Plummer C
J Geriatr Oncol; 2019 Sep; 10(5):685-689. PubMed ID: 30733001
[TBL] [Abstract][Full Text] [Related]
14. Anthracycline-induced cardiotoxicity and senescence.
Booth LK; Redgrave RE; Folaranmi O; Gill JH; Richardson GD
Front Aging; 2022; 3():1058435. PubMed ID: 36452034
[TBL] [Abstract][Full Text] [Related]
15. Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act.
Lubberts S; Meijer C; Demaria M; Gietema JA
Crit Rev Oncol Hematol; 2020 Jul; 151():102963. PubMed ID: 32446180
[TBL] [Abstract][Full Text] [Related]
16. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological foundations of cardio-oncology.
Minotti G; Salvatorelli E; Menna P
J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
[TBL] [Abstract][Full Text] [Related]
18. Predicting and preventing the cardiotoxicity of cancer therapy.
Anderson B; Sawyer DB
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
[TBL] [Abstract][Full Text] [Related]
19. Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions.
Wang S; El Jurdi N; Thyagarajan B; Prizment A; Blaes AH
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542292
[TBL] [Abstract][Full Text] [Related]
20. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
